Replies to post #343 on Vascular Biogenics Ltd (VBLT)

[gr8db8]

Data for rGBM and ovarian supports VB-111 effectiveness. But naysayers / shorts will claim that there's not enough data points and they're correct. Phase 3 will completely eliminate all doubts one way or another.